Hospire names Svend Andersen to lead Europe, Middle East and Africa

06-Oct-2010 - United Kingdom
Hospira announced that Svend Andersen has been named corporate vice president and president, Europe, Middle East and Africa (EMEA). In this capacity, he will be responsible for developing strategy, delivering growth and attaining market leadership in the EMEA region. Andersen, 48, will report to Ron Squarer, senior vice president and chief commercial officer, effective Nov. 1, 2010. Under Andersen's leadership, Hospira will advance its EMEA strategy, which includes expanding the company's geographic footprint, growing its leading position in generic injectable pharmaceuticals and biosimilars, and increasing market share in infusion devices and consumables. Sales in the EMEA comprised 14 percent of Hospira's total sales in 2009. Most recently, Andersen served as executive vice president, Western Europe, at Actavis. There, he drove significant growth in the company's hospital business, led five acquisitions, opened subsidiaries in six European countries and, in 2009, launched over 300 products and brands. He led the regional expansion from eight to 15 markets, and bolstered the company's positions in the United Kingdom, Germany, Benelux and the Nordic countries. He also was responsible for commercial operations, finance, supply, regulatory and business development, with oversight of legal and intellectual property. Prior to joining Actavis, Andersen was vice president, general manager at Alpharma, a global specialty pharmaceutical company, where he directed strategy, restructured the organisation and revitalised the business prior to its acquisition by Actavis. He has also served as vice president, commercial operations, at Ferrosan, a consumer healthcare and medical devices company, and worked as a business consultant to four start-up companies. Andersen earned his Bachelor of Science in Economic Sciences and degrees in International Marketing; Organisational Behaviours and Strategic Planning; and Advanced Advertising, all at Copenhagen Business School.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances